Description

The Tumor Markers Test Kit YGA1339 // YGA1356 is an advanced diagnostic tool designed to detect various tumor markers, helping healthcare providers to identify early signs of cancer. This kit is compatible with Chemiluminescence Immunoassay Analyzers, such as YR06389 and YR06390, ensuring smooth integration into laboratory workflows. The test kit includes a broad range of tumor markers, such as AFP (Alpha-fetoprotein), CEA (Carcinoembryonic Antigen), CA125, CA15-3, CA19-9, t-PSA (Total Prostate-Specific Antigen), f-PSA (Free Prostate-Specific Antigen), SCC (Squamous Cell Carcinoma Antigen), and many others. By analyzing these parameters, clinicians can detect the elevation of tumor markers in blood samples, enabling them to diagnose and monitor various types of cancers, including prostate, ovarian, and liver cancers.

The test kit provides valuable insights into the patient’s condition, helping to tailor personalized treatment plans. The CLIA analysis mode and its compatibility with alkaline phosphatase platforms ensure high reliability and efficiency, making it an essential tool for early cancer detection and management.

Market Price

The Tumor Markers Test Kit YGA1339 // YGA1356 is available at competitive prices, typically ranging from $2.50 to $5.00 per test, depending on the quantity ordered (50T/BOX, 100T/BOX, etc.) and specific configurations required. Laboratories and healthcare facilities can access tailored pricing based on their testing volume and needs through the Kalstein Plus platform. You can easily request a customized quote that fits your budget and operational requirements.

Frequently Asked Questions

1. What tumor markers does the Tumor Markers Test Kit test for? The kit tests for a wide range of tumor markers, including AFP, CEA, CA125, CA15-3, CA19-9, t-PSA, f-PSA, SCC, and others, enabling the diagnosis of various cancers.

2. What analysis method does the kit use? The test kit uses Chemiluminescence Immunoassay (CLIA) for accurate and reliable analysis, ensuring precise detection of tumor markers in blood samples.

3. Can the kit be used with all Chemiluminescence Immunoassay Analyzers? Yes, the Tumor Markers Test Kit is compatible with Chemiluminescence Immunoassay Analyzers like the YR06389 and YR06390 models, offering flexibility for various lab setups.

Advantages and Disadvantages

Advantages:

• Comprehensive range of tumor markers, helping detect and monitor various cancers.
• High accuracy and sensitivity using Chemiluminescence Immunoassay (CLIA).
• Compatible with multiple CLIA platforms, allowing for seamless integration into laboratory workflows.
• Helps in early diagnosis and effective cancer management, which is crucial for improving patient outcomes.

Disadvantages:

• The kit requires storage at 2-8°C, which may restrict its portability or flexibility in transport.
• It may be expensive for smaller clinics or healthcare facilities with lower testing volumes.

Product Use in the Field

The Tumor Markers Test Kit YGA1339 // YGA1356is widely used in clinical laboratories, oncology centers, and hospitals for detecting and monitoring cancer. Healthcare professionals rely on this test kit to identify early stages of various cancers, including prostate, ovarian, and liver cancers. It is also used to monitor disease progression and response to treatment in patients undergoing cancer therapy. The kit’s compatibility with automated testing platforms allows for efficient and accurate results, helping clinicians make informed decisions about patient care.

Recommendations

To ensure optimal performance and reliable results from the Tumor Markers Test Kit:

• Store the kit at the recommended temperature of 2-8°C to preserve the integrity of the reagents.
• Regularly calibrate the Chemiluminescence Immunoassay Analyzer to maintain the accuracy of the test results.
• Incorporate the test kit into automated lab workflows to reduce errors and improve efficiency.

Technical Specifications